Clearside Biomedical (United States)
- Research works
- 77 ▲ 53% vs 2013–17
- Citations
- 1.6k 21.1 per fractional work
- Top-10% rate
- 37.5% record average 16.5%
- Open access
- 80% world 28%
Not ranked overall: Clearside Biomedical (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 7.7×. Every wedge is a field page.
Who are the top researchers at Clearside Biomedical (United States)?
Ranked on the composite score, Glenn Noronha and Viral Kansara lead among researchers whose main affiliation is Clearside Biomedical (United States).
- 1 Glenn Noronha United States · #549,417 worldwide 54 citations · 15 works
- 2 Viral Kansara United States · #887,234 worldwide 48 citations · 15 works
Which keywords describe research at Clearside Biomedical (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Macular Degeneration, Inflammation, Vascular Endothelial Growth Factor, Diabetic Retinopathy, Oxidative Stress, Intravitreal Injection, Choroidal Thickness and Retinal Pigment Epithelium.
- Myopia
- Immunity
- Vessel Segmentation
- Cardiovascular Risk
- Uveitis
- Retinopathy
- Behçet's Disease
- Policy Compliance
- Retinal Artery Occlusion
- Autoimmunity
- COVID-19
- Retinal Stem Cells
- Epidemiology
- Ocular Hypertension
- Intraocular Pressure
- Glaucoma
- Retinal Pigment Epithelium
- Intravitreal Injection
- Diabetic Retinopathy
- Inflammation
- Macular Degeneration
- Vascular Endothelial Growth Factor
- Oxidative Stress
- Choroidal Thickness
- Optical Coherence Tomography
- Optic Nerve
- Risk Factors
- Retinal Ganglion Cells
- Gene Therapy
- Retinitis Pigmentosa
- Risk Management
- Ocular Findings
- Information Security
- Security Awareness
- Graves' Ophthalmopathy
- Thyroid-Associated Ophthalmopathy
- OCT Imaging
- Retinal Disease
- Geosynthetics
- Soil Reinforcement
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Macular Degeneration15▲ 155×3 topics
- Inflammation13▲ 7.4×15 topics
- Vascular Endothelial Growth Factor12▲ 150×3 topics
- Diabetic Retinopathy11▲ 171×2 topics
- Oxidative Stress10▲ 7.4×6 topics
- Intravitreal Injection10▲ 185×2 topics
- Choroidal Thickness10▲ 244×1 topic
- Retinal Pigment Epithelium10▲ 244×1 topic
- Optical Coherence Tomography9▲ 99×3 topics
- Glaucoma8▲ 66×3 topics
- Optic Nerve7▲ 97×2 topics
- Intraocular Pressure6▲ 76×2 topics
- Risk Factors6▲ 7.5×2 topics
- Ocular Hypertension6▲ 117×1 topic
- Retinal Ganglion Cells6▲ 58×1 topic
- Epidemiology5▲ 1.62×14 topics
- Gene Therapy5▲ 25×3 topics
- Retinal Stem Cells4▲ 124×1 topic
- Retinitis Pigmentosa4▲ 124×1 topic
- COVID-193▲ 6.2×2 topics
- Risk Management3▲ 12×2 topics
- Autoimmunity3▲ 17×2 topics
- Ocular Findings3▲ 128×1 topic
- Retinal Artery Occlusion3▲ 128×1 topic
- Information Security2▲ 62×2 topics
- Policy Compliance2▲ 114×1 topic
- Security Awareness2▲ 114×1 topic
- Behçet's Disease2▲ 94×1 topic
- Graves' Ophthalmopathy2▲ 96×1 topic
- Retinopathy2▲ 138×2 topics
- Thyroid-Associated Ophthalmopathy2▲ 96×1 topic
- Uveitis2▲ 94×1 topic
- OCT Imaging2▲ 64×2 topics
- Cardiovascular Risk2▲ 5.7×2 topics
- Retinal Disease2▲ 52×1 topic
- Vessel Segmentation2▲ 58×1 topic
- Geosynthetics1▲ 44×1 topic
- Immunity1▲ 5.5×4 topics
- Soil Reinforcement1▲ 33×1 topic
- Myopia1▲ 27×2 topics
Which research topics does Clearside Biomedical (United States) publish most on?
By volume in 2022–2025: Retinal Diseases and Treatments, BIM and Construction Integration, Glaucoma and retinal disorders and Systemic Lupus Erythematosus Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Retinal Diseases and Treatments Ophthalmology 2 works
- 2 BIM and Construction Integration Building and Construction 1 works
- 3 Glaucoma and retinal disorders Ophthalmology 1 works
- 4 Systemic Lupus Erythematosus Research Rheumatology 1 works
- 5 Ruminant Nutrition and Digestive Physiology Agronomy and Crop Science 1 works
- 6 Ocular Diseases and Behçet’s Syndrome Ophthalmology 1 works
- 7 Retinal and Optic Conditions Ophthalmology 1 works
- 8 Retinal Development and Disorders Molecular Biology 0 works
- 9 Animal Nutrition and Physiology Animal Science and Zoology 0 works
- 10 Epigenetics and DNA Methylation Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Clearside Biomedical (United States)'s research output changed?
Output in 2018–2022 was 53% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Alpharetta
- Pediatrics and Genetics
- Engineering Associates (United States)
- Institute for Advanced Medical Research
- Chinese Medical Center
- Biota Pharmaceuticals (United States)
- Alimera Sciences (United States)
- Veloxiti (United States)
- Rolta (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.